Belimumab in kidney transplantation - Authors' reply

Affiliations

¹ Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
² Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; ImmunoInflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
³ ImmunoInflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.
⁴ Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: mrc38@cam.ac.uk.

Comment

Gemma D Banham et al. Lancet. 2019.

. 2019 Mar 2;393(10174):875-876.

doi: 10.1016/S0140-6736(18)33066-6.

¹ Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
² Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; ImmunoInflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
³ ImmunoInflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, UK.
⁴ Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0SP, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: mrc38@cam.ac.uk.

No abstract available

Comment on

Belimumab in kidney transplantation.
Ahmed S. Ahmed S. Lancet. 2019 Mar 2;393(10174):874. doi: 10.1016/S0140-6736(18)33074-5. Lancet. 2019. PMID: 30837143 No abstract available.
Belimumab in kidney transplantation.
Tampaki EC, Tampakis A, Gürke L, Pantos C. Tampaki EC, et al. Lancet. 2019 Mar 2;393(10174):874-875. doi: 10.1016/S0140-6736(18)33075-7. Lancet. 2019. PMID: 30837144 No abstract available.